Inside this note
Altreno is a prescription tretinoin lotion with a defined strength and an acne indication. Those details make it a useful addition to a review library often dominated by online subscription services. The medicine, the clinician who prescribes it, and the pharmacy that supplies it are three different parts of a purchasing decision.
This review examines the US prescribing information available through DailyMed, checked September 26, 2026. It does not describe personal use or a comparison trial against CoreAge Rx. Our sponsored partner appears first across this publication; that commercial position does not establish that its formulation performs better than Altreno.
THE NOTE TO KEEP
Altreno has its own acne indication and vehicle; neither a familiar ingredient nor a lotion texture proves equivalence to another prescription.
The product identity is unusually important here
The reviewed product is Altreno tretinoin lotion 0.05%. Each gram contains 0.5 milligrams of tretinoin. The label describes an opaque, pale-yellow lotion and identifies its use for acne vulgaris in patients nine years and older. An age threshold in a label is not permission to share a prescription with a child or another household member.
Altreno is not simply a bottle of cosmetic retinol with stronger wording. Nor is it the same product as every cream carrying 0.05% on the carton. The delivery base, ingredients, instructions, and supporting evidence belong to the named preparation. Our Retin-A cream review shows how another tretinoin label answers a different set of formulation questions.
What the clinical evidence measured
The Altreno label describes two randomized, double-blind, multicenter trials involving 1,640 people aged nine and older with acne. The studies evaluated acne severity and inflammatory and noninflammatory lesion counts at week 12. The comparator was the lotion vehicle, not a different online prescription service or a compounded combination cream.
That study design supports a discussion of the labeled acne treatment. It does not establish a fine-wrinkle benefit for this lotion, a ranking among tretinoin brands, or an individual deadline for clearer skin. The RENOVA 0.02% cream label addresses a specific fine-facial-wrinkle indication alongside comprehensive skincare and sunlight avoidance. We keep that evidence attached to RENOVA rather than treating it as a transferable promise for Altreno.
A clinician may discuss uses beyond a product’s labeled indication. If that happens, ask which goal is being treated, what evidence informs the choice, and how progress will be assessed. A review should not quietly replace that conversation with an anti-aging claim because two medicines contain tretinoin.
The lotion contains more than its active ingredient
The published base includes glycerin, mineral oil, sodium hyaluronate, soluble collagen, and other ingredients. Their presence helps identify the formulation; it does not establish that every person will find it soothing or that irritation cannot occur. An ingredient list is also not an independent comparative trial of hydration.
A particularly important warning concerns fish allergy. The prescribing information says Altreno contains soluble fish proteins and calls for caution in people with known sensitivity or allergy to fish. It advises contacting a healthcare provider for itching or hives. Someone with that history should raise it before starting, rather than assuming that topical application makes the issue irrelevant.
We have not assigned a texture score, scent rating, or sensitive-skin award. Those would imply testing that this editorial desk did not perform. Your allergy history and the full ingredient list give a clinician more useful information than a generic description such as “gentle lotion.”
Irritation and sun exposure still matter
The label lists application-site dryness, pain, redness, irritation, and exfoliation among adverse reactions. It advises avoiding application to sunburned or eczematous skin and reducing unprotected ultraviolet exposure. Sunscreen and protective clothing remain relevant; a nighttime medicine does not remove the following day’s sun-protection needs.
The prescriber determines how to respond to troublesome irritation. The label discusses possible changes, including moisturizer use, reduced application frequency, or discontinuation, depending on severity. This review does not select one of those actions for an individual reader or turn them into a universal starting schedule. Our irritation guide helps organize symptoms and questions for that discussion.
Tell the clinician about pregnancy, pregnancy plans, breastfeeding, other skin conditions, and all medications and skincare products. A short online questionnaire may not capture an important detail unless you add it. Follow the directions supplied for your own prescription, including where the medicine should and should not be applied.
Price and supply require a pharmacy-specific check
We did not verify a current cash price, insurance benefit, savings-card eligibility, or pharmacy inventory for Altreno. The labeling identifies package configurations, including tubes and a pump, but a listed package is not proof that a particular pharmacy stocks it today. Ask for the prescribed quantity and the complete amount due.
Compare a pharmacy quote with an online service only after separating the drug charge, consultation, follow-up, shipping, and future refills. The cost note explains why a monthly advertisement and a single tube price are not directly interchangeable. A favorable quote also says nothing by itself about whether the medicine suits the treatment goal.
Keep the packaging instructions with the prescription
Altreno’s storage section specifies 68–77°F, with permitted excursions to 59–86°F, protection from freezing, and upright storage for the pump. These are product-specific instructions. Do not replace them with a general skincare-fridge rule or assume a hot delivery is acceptable because the lotion looks unchanged.
Our storage and travel guide explains the information to collect if a shipment or trip raises a temperature question. The pharmacy can assess the actual product and circumstances; this website cannot determine potency from a photograph or the weather forecast.
A useful comparison ends with clearer questions
For Altreno, the strongest publicly verifiable points are its exact strength, labeled acne use, documented trial design, and specific precautions. Its personal affordability, availability, tolerability, and suitability still require individual confirmation. That is a meaningful review outcome even without a star rating.
For the commercial partner featured on this site, the Smooth Move review records a different public formula and important concentration gaps. Reading the two together should clarify what needs to be established, rather than suggest that branded lotion and compounded combination cream are automatically equivalent choices.
CHECK THE ORIGINALS
Sources for this note
Individual source check dates appear below. Commercial pages describe the seller’s offer; clinical sources have their own evidence limits.
- MedlinePlus — Tretinoin topical ↗
National Library of Medicine patient information on uses, precautions, side effects, and following prescription directions. Checked 2026-09-26.
- DailyMed — RENOVA tretinoin cream 0.02% label ↗
Label updated February 24, 2026. The fine-wrinkle indication is product specific, adjunctive to comprehensive skincare and sun avoidance. Checked 2026-09-26.
- FDA — Understanding the risks of compounded drugs ↗
Explains why compounded finished preparations do not receive FDA premarket approval for safety, effectiveness, or quality. Checked 2026-09-26.
- DailyMed — Altreno tretinoin lotion 0.05% ↗
US record updated March 2, 2020; acne indication age 9+, 0.05% lotion, fish-protein warning, vehicle-controlled acne trials and product-specific storage. Not a comparative wrinkle trial or a pharmacy price record. Checked 2026-09-26.